Hints and tips:
...Sinclair Pharma raised nearly £40m ($62m) of equity in two rounds....
...“It hasn’t been great, but then I’d argue that it hasn’t been terribly bad either,” says Shawn Manning, a biotech analyst at Singer Capital, of the recent investment climate....
International Edition